Filing Flows

Filing Flows › Staar Surgical (STAA) › Q2 2025

Staar Surgical (STAA) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 6, 2025

Staar Surgical (STAA) reported revenue of $44.3M for the second quarter 2025 (Q2 2025), -55% from a year earlier and +4% from the quarter before. Operating margin was -67.6%, net loss $16.8M (37.9% of revenue).

Revenue$44.3M
Year over year-55%
Quarter over quarter+4%
Operating margin-67.6%
Net earnings−$16.8M

Staar Surgical, Q2 2025: revenue $44.3M (-55% year over year), operating margin -67.6%, net loss $16.8M, operating cash flow −$27.2M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$44.3M+4%-55%
Operating profit−$30.0M——
Net earnings−$16.8M——
Operating cash flow−$27.2M——

What changed

Revenue was $44.3M in Q2 2025, down 55% year over year and up 4% from the previous quarter.

Gross margin was 74.0%, down 5.2 points from a year earlier. Operating costs exceeded revenue by $30.0M, an operating margin of -67.6%. Operating expenses fell 6% while revenue fell 55%. The quarter ended with a net loss of $16.8M, narrower than the previous quarter's $54.2M loss.

Operating cash flow was −$27.2M. Non-cash charges added back $2.0M of depreciation and $7.8M of share-based compensation. Working capital and other items used $20.2M. Capital expenditures of $1.8M exceeded it, leaving free cash flow of −$29.0M.

Questions

What was Staar Surgical's revenue in the second quarter 2025?

Staar Surgical (STAA) reported revenue of $44.3M for the second quarter 2025 (Q2 2025), -55% from a year earlier and +4% from the quarter before.

Was Staar Surgical profitable in the second quarter 2025?

Operating loss was $30.0M (-67.6% of revenue) and net loss $16.8M.

Open the interactive Sankey →

Source: Staar Surgical 10-Q on SEC EDGAR.